Partner Don Schroeder was quoted in a Society for Human Resource Management (SHRM) article, “New NLRB Acting Chairman May Tilt Board Pro-Business,” covering President Donald Trump’s naming of Philip Miscimarra as acting chairman of the National Labor Relations Board (NLRB) and the agency’s shift toward business interests.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."